X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2109) 2109
gastroenterology & hepatology (1327) 1327
primary sclerosing cholangitis (1301) 1301
male (1021) 1021
female (929) 929
adult (715) 715
middle aged (686) 686
primary biliary-cirrhosis (525) 525
cholangitis (498) 498
cholangitis, sclerosing - drug therapy (475) 475
liver (433) 433
aged (428) 428
ursodeoxycholic acid (384) 384
ursodeoxycholic acid - therapeutic use (347) 347
treatment outcome (338) 338
liver diseases (331) 331
risk factors (325) 325
liver transplantation (324) 324
cholangitis, sclerosing - diagnosis (318) 318
cholangitis, sclerosing - complications (303) 303
sclerosing cholangitis (288) 288
animals (278) 278
diagnosis (275) 275
inflammatory bowel disease (259) 259
ulcerative-colitis (255) 255
inflammatory-bowel-disease (252) 252
gastroenterology and hepatology (244) 244
autoimmune hepatitis (241) 241
bile (241) 241
surgery (241) 241
prognosis (240) 240
adolescent (237) 237
medicine & public health (237) 237
immunosuppressive agents - therapeutic use (236) 236
disease (233) 233
ulcerative colitis (228) 228
hepatitis (220) 220
cholestasis (212) 212
gastroenterology (212) 212
diagnosis, differential (205) 205
retrospective studies (203) 203
liver - pathology (199) 199
cholagogues and choleretics - therapeutic use (197) 197
primary biliary cirrhosis (193) 193
transplantation (193) 193
therapy (190) 190
hepatology (185) 185
biopsy (184) 184
cirrhosis (181) 181
care and treatment (175) 175
child (172) 172
cholangitis, sclerosing - pathology (169) 169
chronic active hepatitis (163) 163
crohns-disease (162) 162
autoimmune pancreatitis (161) 161
risk-factors (161) 161
liver cirrhosis (157) 157
natural-history (157) 157
oncology (154) 154
medicine, general & internal (152) 152
follow-up studies (149) 149
autoimmune diseases - drug therapy (148) 148
immunology (148) 148
cholangiopancreatography, endoscopic retrograde (144) 144
pharmacology & pharmacy (143) 143
patients (142) 142
recurrence (141) 141
young adult (141) 141
cholangiocarcinoma (140) 140
cholangitis, sclerosing - immunology (139) 139
cholangitis, sclerosing - therapy (139) 139
health aspects (138) 138
colitis, ulcerative - complications (136) 136
fibrosis (135) 135
abridged index medicus (134) 134
cancer (134) 134
liver cirrhosis, biliary - drug therapy (132) 132
dose ursodeoxycholic acid (130) 130
management (130) 130
prevalence (130) 130
autoimmune diseases - diagnosis (128) 128
cholangitis, sclerosing - etiology (123) 123
hepatitis, autoimmune - diagnosis (122) 122
analysis (121) 121
review (119) 119
internal medicine (118) 118
time factors (118) 118
disease progression (114) 114
double-blind (114) 114
research (114) 114
hepatitis, autoimmune - drug therapy (113) 113
pathogenesis (112) 112
liver-transplantation (111) 111
cholangitis, sclerosing - surgery (110) 110
inflammatory bowel diseases (110) 110
cholangiography (109) 109
mice (109) 109
liver function tests (108) 108
development and progression (106) 106
immunoglobulin g - blood (106) 106
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2556) 2556
German (70) 70
French (31) 31
Japanese (27) 27
Spanish (15) 15
Norwegian (7) 7
Russian (6) 6
Chinese (5) 5
Hungarian (4) 4
Korean (4) 4
Bulgarian (3) 3
Czech (3) 3
Danish (3) 3
Finnish (3) 3
Italian (3) 3
Polish (3) 3
Dutch (2) 2
Portuguese (2) 2
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2008, Volume 134, Issue 3, pp. 706 - 715
Journal Article
Journal Article
Journal Article
Seminars in Liver Disease, ISSN 0272-8087, 02/2016, Volume 36, Issue 1, pp. 005 - 014
Journal Article
Gut, ISSN 0017-5749, 04/2010, Volume 59, Issue 4, pp. 521 - 530
...  Chronic cholangiopathies such as primary sclerosing cholangitis (PSC) and primary biliary cirrhosis are characterised by progressive inflammation... 
SIGNALING PATHWAYS | IN-VITRO | HEPATIC STELLATE CELLS | DOSE URSODEOXYCHOLIC ACID | TRANSPORTER EXPRESSION | ACTIVATED-RECEPTOR-GAMMA | GENE-EXPRESSION | PPAR-GAMMA | GASTROENTEROLOGY & HEPATOLOGY | NF-KAPPA-B | TRANSCRIPTIONAL REGULATION | Cholangitis, Sclerosing - drug therapy | Epithelial Cells - metabolism | Bile Ducts - metabolism | Epithelial Cells - drug effects | Male | Liver Cirrhosis, Experimental - drug therapy | PPAR gamma - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Inflammation Mediators - metabolism | Cholangitis, Sclerosing - metabolism | Drug Evaluation, Preclinical - methods | Bile Acids and Salts - biosynthesis | Bile Ducts - drug effects | Curcumin - therapeutic use | Cells, Cultured | Curcumin - pharmacology | Mice, Knockout | Cholangitis, Sclerosing - pathology | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Fibroblasts - drug effects | Cell Proliferation - drug effects | Mice | Bile - secretion | ATP Binding Cassette Transporter, Sub-Family B - genetics | Mitogen-Activated Protein Kinase 1 - metabolism | Turmeric | Prevention | Usage | Care and treatment | Peroxisomes | Immune response | Extracellular signal-regulated kinases | Cholangitis | Physiological aspects | Models | Research | Health aspects | Genotype & phenotype | Diet | Rodents | Inflammation | Kinases | Laboratory animals | Gene expression | Liver cirrhosis | Bile | cholangiopathy | portal fibrosis | Mdr2 | sclerosing cholangitis | curcumin
Journal Article
Journal of hepatology, ISSN 0168-8278, 2016, Volume 64, Issue 3, pp. 674 - 681
Journal Article
Journal Article